All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ1638 | Anti-OAS1 (2D4) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 2D4 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1639 | Anti-OAS1 (CBXO-0014) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXO-0014 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1640 | Anti-OAS1 (CBXO-0015) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXO-0015 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1641 | Anti-OAS1 (CBXO-0016) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXO-0016 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1642 | Anti-OAS1 (CBXO-0331) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXO-0331 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5062 | Anti-OAS1 (2D4) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2D4 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5063 | Anti-OAS1 (CBXO-0014) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXO-0014 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5064 | Anti-OAS1 (CBXO-0015) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXO-0015 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5065 | Anti-OAS1 (CBXO-0016) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXO-0016 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5066 | Anti-OAS1 (CBXO-0331) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXO-0331 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION